RxDoctor Payments Data

Jennifer Park, MD

Family Medicine · Lancaster, PANPI 1326307588

Payments from drug & device makers

$556in general payments, 2019–2025

Across 27 payments — averaging $20.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi-aventis U.S. LLC$126
  • Pfizer$121
  • Novo Nordisk$51
  • Boehringer Ingelheim$50
  • Abbott$41
  • AstraZeneca$38
  • plus $129 from 6 others

What the payments were for

  • Food & beverage$556100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$556 in reported general payments places this provider in the 60th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$61,809
Medicare patients
175
Services billed
762

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide32$38,198
EliquisApixaban34$27,995
MounjaroTirzepatide13$13,332
Trelegy ElliptaFluticasone/Umeclidin/Vilanter13$10,888
JanuviaSitagliptin Phosphate11$7,225
SynthroidLevothyroxine Sodium32$2,677
SymbicortBudesonide/Formoterol Fumarate11$2,609
Albuterol Sulfate HfaAlbuterol Sulfate59$2,021
Atorvastatin Calcium200$1,920
Zolpidem Tartrate42$1,458
Pantoprazole Sodium68$1,045
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$982
Amlodipine Besylate130$846
Losartan Potassium88$786
Metoprolol Succinate66$769

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$51$38,19832 claims
PfizerEliquis$121$27,99534 claims
GSKTrelegy Ellipta$27$10,88813 claims
MerckJanuvia$13$7,22511 claims
AstraZenecaSymbicort$38$2,60911 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in Lancaster

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →